WomenInc.
  • Business / Worklife
    • 2023 Most Influential Women Corporate Board Directors
  • Corporate Boards
  • Entrepreneurship
  • Entertainment
  • Indulge
  • Contact
  • Shop
WomenInc.
  • Business / Worklife
    • 2023 Most Influential Women Corporate Board Directors
  • Corporate Boards
  • Entrepreneurship
  • Entertainment
  • Indulge
  • Contact
  • Shop
Corporate Boards

Autolus Announces Appointment of Linda Bain to its Board of Directors

by WomenInc Staff June 21, 2018
June 21, 2018

Autolus Therapeutics Limited, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced that it is appointing Linda Bain to the Autolus board of directors effective prior to the closing of Autolus’ planned initial public offering.

Dr. Christian Itin, Autolus’ Chairman and Chief Executive Officer, commented:

“We are very pleased to welcome Linda to the Board. Linda has highly relevant expertise in finance and operations and broad executive experience in growth-stage biopharma companies. We are looking forward to working with Linda and believe she will be an invaluable resource to Autolus as we progress our programmed T cell therapies through development and towards commercialisation.”

Linda Bain said:

“It is an exciting time at Autolus. I look forward to working with the experienced management team and other Board members to realise the full potential of Autolus’ proprietary technology and as we strive to become one of the world’s leading programmed T cell companies.”

Linda is a seasoned business executive with over 20 years of finance and audit experience in the biotech and pharmaceutical industry. She currently serves as Chief Financial Officer of Codiak BioSciences, Inc., a privately held company in the emerging field of exosome therapeutics. Prior to this, she was chief financial officer and treasurer at Avalanche Biotechnologies, Inc. from April 2014 until November 2015. She previously served as chief accounting officer and vice president of finance and business operations from October 2011 to March 2014 at bluebird bio, Inc., and as treasurer from June 2013 to March 2014. Linda has held senior roles at Genzyme Corporation, including most recently vice president of finance. Earlier in her career, she served in senior finance roles at Fidelity Investments and AstraZeneca plc and as an auditor at Deloitte & Touche.

Linda received her B.S in Accounting and Business Administration and an Honors Degree in Accounting and Business Administration from the University of the Free State, South Africa. She is a Certified Public Accountant.

 

Linda Bainwomen on boardswomeninc

Related Posts

Herbalife Welcomes Lynda Cloud to its Board of...

Under Armour appoints Dawn N. Fitzpatrick to its...

Levi Strauss & Co. Appoints Artemis Patrick to...

Analog Devices Appoints Andrea F. Wainer to its...

The Hartford Appoints Annette Rippert To Its Board...

JPMorganChase Elects Michele G. Buck to its Board...

Netflix Executive Bela Bajaria Elected to Board of...

AppLovin appoints Barbara Messing to its Board of...

Women Inc. Announces the 2023 Most Influential Corporate...

Exelon Appoints Anna Richo to Board of Directors

Upcoming Issue

2023 Most Influential Women Corporate Board Directors List

2022 Most Influential Women Executives List

Categories

  • Business (180)
  • Business / Worklife (108)
  • C-Suite (99)
  • Corporate Boards (231)
  • Diversity & Inclusion (14)
  • Editorials (8)
  • Editors Picks (2)
  • Entertainment (74)
  • Entrepreneurship (40)
  • Gender Diversity (10)
  • Indulge (30)
  • Movers & Shakers (18)
  • Professional (11)
  • Start-Ups (2)
  • WorkLife (31)

Subscribe to our Newsletter for new blog posts, event announcements & new photos. Big things coming!

Copyright ©2019 Women Inc.

WomenInc.
  • Business / Worklife
    • 2023 Most Influential Women Corporate Board Directors
  • Corporate Boards
  • Entrepreneurship
  • Entertainment
  • Indulge
  • Contact
  • Shop
Copyright ©2019 Women Inc.